Screener
USANA Health Sciences USNA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: USANA Health Sciences’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 2:37 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0000896264-26-000056
| Line item | Three months ended / July 4,2026 | Three months ended / June 28,2025 | Six months ended / July 4,2026 | Six months ended / June 28,2025 |
|---|---|---|---|---|
| Net (loss) earnings attributable to USANA | $(21,382) | $9,655 | $(13,867) | $19,057 |
| (Loss) earnings per common share attributable to USANA | ||||
| Basic | $(1.16) | $0.52 | $(0.75) | $1.01 |
| Diluted | $(1.16) | $0.52 | $(0.75) | $1.01 |
| Weighted average common shares outstanding | ||||
| Basic | 18,486 | 18,513 | 18,442 | 18,781 |
| Diluted | 18,486 | 18,536 | 18,442 | 18,811 |
| Comprehensive income (loss): |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's EPS (diluted)?
- USANA Health Sciences (USNA) reported EPS (diluted) of -$1.16 in Q2 2026.
- How has USANA Health Sciences's EPS (diluted) changed year-over-year?
- USANA Health Sciences's EPS (diluted) decreased by 323.1% year-over-year, from $0.52 to -$1.16.
- What is the long-term trend for USANA Health Sciences's EPS (diluted)?
- Over 2 years (2022 to 2024), USANA Health Sciences's EPS (diluted) has grown at a -21.9% compound annual growth rate (CAGR), from $3.59 to $2.19.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about USANA Health Sciences's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude